CN Stock MarketDetailed Quotes

600594 Guizhou Yibai Pharmaceutical

Watchlist
  • 4.32
  • -0.18-4.00%
Market Closed Dec 13 15:00 CST
3.42BMarket Cap-14.50P/E (TTM)

Guizhou Yibai Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-9.57%619.88M
12.86%760.22M
12.99%770.6M
18.08%699.47M
-24.33%685.49M
-16.72%673.61M
48.05%682.01M
56.04%592.36M
26.11%905.91M
8.42%808.89M
Notes receivable and accounts receivable
-29.41%492.61M
-22.17%460.1M
-9.30%536.77M
22.29%692.32M
14.63%697.86M
-32.52%591.16M
-22.41%591.82M
-18.97%566.13M
-23.01%608.81M
4.08%876.11M
-Notes receivable
-55.63%252.85M
-28.62%239.51M
-0.73%322.4M
71.30%465.26M
99.95%569.86M
-35.15%335.54M
-28.77%324.79M
-24.09%271.61M
-39.15%285M
-9.40%517.39M
-Accounts receivable
87.31%239.75M
-13.70%220.59M
-19.72%214.37M
-22.91%227.06M
-60.47%128M
-28.74%255.62M
-12.96%267.03M
-13.60%294.53M
0.46%323.81M
32.51%358.72M
Other receivables (including interest and dividends)
-55.00%26.76M
-43.72%35.75M
-39.57%38.82M
-40.66%33.26M
-13.83%59.47M
55.16%63.52M
24.98%64.24M
45.90%56.05M
2.19%69.02M
-28.49%40.94M
-Other receivable
----
-43.72%35.75M
----
----
----
55.16%63.52M
----
----
----
-28.49%40.94M
Advance payment
-11.66%16.38M
63.85%27.72M
232.11%55.28M
153.57%36.21M
-53.99%18.54M
-34.87%16.92M
-61.42%16.65M
4.49%14.28M
36.06%40.3M
83.31%25.98M
Inventories
-15.52%552.83M
-4.47%601.39M
-1.48%614.26M
-6.15%586.65M
10.05%654.37M
5.84%629.5M
7.97%623.46M
12.70%625.08M
13.50%594.62M
14.61%594.77M
Receivable financing
----
-79.49%30.78M
----
----
----
--150.1M
--148.69M
--156.1M
33.17%207.12M
----
Other current assets
12.37%24.16M
-65.52%27.53M
-32.13%20M
-30.66%21.23M
-14.43%21.5M
296.36%79.83M
-14.11%29.46M
-12.46%30.63M
-46.48%25.12M
-48.66%20.14M
Total current assets
-18.93%1.73B
-11.84%1.94B
-5.59%2.04B
1.40%2.07B
-12.80%2.14B
-6.85%2.2B
11.74%2.16B
18.64%2.04B
5.07%2.45B
6.74%2.37B
Non Current assets
Other equity investment
2.50%1.63M
-20.42%1.63M
-20.42%1.63M
-22.36%1.59M
-29.08%1.59M
-13.23%2.05M
-13.66%2.05M
-21.56%2.05M
-39.85%2.24M
-46.47%2.36M
Long-term equity investment
0.18%35.22M
0.04%35.22M
-0.45%35.13M
-0.97%35.07M
-0.79%35.16M
-0.74%35.21M
-0.94%35.29M
-0.69%35.41M
-0.91%35.43M
-1.75%35.47M
Fixed assets
----
-5.28%1.64B
----
----
----
48.61%1.73B
----
----
----
-3.21%1.16B
Constru in process
----
-71.46%6.48M
----
----
----
-96.28%22.72M
----
----
----
93.83%610.86M
Productive biological assets
244.00%15.91M
181.43%12.64M
114.17%9.23M
50.78%6.25M
20.40%4.62M
21.54%4.49M
20.79%4.31M
22.31%4.14M
23.27%3.84M
23.65%3.7M
Intangible assets
-8.85%319.02M
-8.76%322.97M
-8.68%326.94M
-8.60%330.89M
-4.37%349.98M
-4.21%353.99M
-4.20%358.03M
-4.36%362.03M
2.32%365.98M
9.97%369.55M
Goodwill
0.00%164.04M
0.00%164.04M
0.00%164.04M
0.00%164.04M
-78.91%164.04M
-78.91%164.04M
-78.91%164.04M
-78.91%164.04M
23.10%777.66M
23.10%777.66M
Long deferred expense
-15.93%106.95M
-15.83%111.8M
-15.91%116.87M
-15.50%123.13M
-18.07%127.21M
-18.79%132.82M
-14.67%138.99M
-14.19%145.72M
-4.32%155.26M
-5.17%163.55M
Deferred tax assets
-63.38%85.09M
-70.21%68.71M
-76.37%54.82M
18.62%55.58M
12.98%232.37M
12.10%230.64M
15.11%232.01M
48.84%46.86M
7.98%205.67M
8.36%205.75M
Usufruct assets
-21.99%31.84M
-21.18%34.03M
-20.64%36.22M
3.21%38.46M
2.68%40.82M
5.10%43.17M
222.10%45.64M
148.19%37.27M
205.80%39.76M
2,076.10%41.08M
Other non current assets
-8.80%67.37M
-12.73%69.53M
-0.17%67.39M
-1.20%62.42M
88.89%73.87M
2.09%79.67M
-8.39%67.5M
-12.74%63.17M
-68.63%39.11M
-46.69%78.04M
Total non current assets
-11.92%2.43B
-11.91%2.46B
-11.63%2.49B
-4.47%2.53B
-19.07%2.76B
-18.97%2.8B
-15.60%2.81B
-16.71%2.65B
10.30%3.42B
13.58%3.45B
Total assets
-14.98%4.17B
-11.88%4.41B
-9.01%4.52B
-1.92%4.6B
-16.45%4.9B
-14.04%5B
-5.57%4.97B
-4.29%4.69B
8.05%5.87B
10.69%5.82B
Liabilities
Current liabilities
Short term loan
-28.36%290.83M
-25.94%426.67M
-28.61%446.01M
-16.95%446.05M
-49.15%405.96M
-29.09%576.09M
10.46%624.72M
18.19%537.11M
10.87%798.28M
44.16%812.4M
Notes payable and accounts payable
-27.95%127.42M
23.20%173.72M
20.37%182.31M
-9.62%135.06M
17.95%176.85M
-10.45%141.01M
3.02%151.46M
6.03%149.43M
21.91%149.93M
40.83%157.47M
-Accounts payable
-27.95%127.42M
23.20%173.72M
20.37%182.31M
-9.62%135.06M
17.95%176.85M
-10.45%141.01M
3.02%151.46M
6.03%149.43M
21.91%149.93M
40.83%157.47M
Contract liabilities
-19.56%25.37M
12.77%47.47M
-8.10%28.89M
-56.27%29.52M
-11.23%31.54M
60.15%42.1M
-43.26%31.44M
24.67%67.51M
1.19%35.53M
-45.44%26.29M
Salaries payable
-17.42%40.55M
-5.13%34.57M
-5.49%34.83M
-6.36%55.99M
-11.11%49.11M
-38.90%36.44M
-22.69%36.85M
10.91%59.79M
-31.84%55.25M
-3.35%59.65M
Taxs payable
-3.06%37.13M
-32.86%34.4M
-54.58%24.92M
-55.47%28.87M
-40.80%38.3M
-12.12%51.23M
-28.19%54.86M
-17.81%64.84M
-3.58%64.69M
28.79%58.3M
Other payable (including interest and dividends)
-34.47%73.31M
-42.59%77.45M
-36.96%88.09M
-5.94%103.8M
-52.50%111.86M
-56.88%134.92M
-27.54%139.75M
-32.03%110.35M
0.68%235.5M
51.14%312.9M
-Interest payable
-68.09%171.2K
-76.76%171.2K
-80.24%171.2K
-84.53%171.2K
-61.56%536.53K
-75.31%736.53K
-72.15%866.53K
-63.89%1.11M
-43.11%1.4M
10.91%2.98M
-Other payable
----
-42.41%77.28M
----
----
----
-56.70%134.18M
----
----
----
51.67%309.91M
Non current liabilities due within one year
169.08%268.67M
56.17%266.92M
53.36%261.35M
-27.03%122.85M
-52.90%99.85M
42.43%170.92M
42.01%170.42M
40.12%168.36M
180.35%211.97M
-46.91%120M
Other current liabilities
-59.44%3.94M
-47.39%6.05M
-41.74%6.64M
-51.42%7.45M
-18.28%9.71M
0.42%11.5M
-16.61%11.4M
5.52%15.33M
-3.66%11.89M
-14.81%11.45M
Total current liabilities
-6.06%867.22M
-8.33%1.07B
-12.11%1.07B
-20.73%929.59M
-40.94%923.18M
-25.30%1.16B
0.19%1.22B
8.65%1.17B
15.94%1.56B
22.03%1.56B
Current liabilities
Long term loan
-36.48%280.8M
-29.68%238.52M
-28.62%248.42M
12.88%387.22M
36.62%442.07M
-20.70%339.19M
7.67%348.04M
8.58%343.04M
-4.36%323.59M
26.90%427.74M
Long term account payable
----
759.85%85.99M
----
----
----
--10M
----
----
----
----
Estimate liabilities
-58.29%271.29K
-42.01%581.85K
-30.94%448.51K
-19.92%520.05K
--650.42K
--1M
--649.44K
--649.44K
----
----
Deferred tax liabilities
6.26%35.04M
-6.04%33.34M
-0.01%35.62M
10.43%37.44M
9.55%32.98M
18.26%35.48M
16.37%35.62M
10.27%33.9M
4.56%30.1M
5.91%30M
Long term deferred income
-11.27%97.99M
-5.15%100.86M
6.15%103.22M
6.12%106.31M
16.43%110.43M
18.37%106.34M
44.47%97.24M
48.20%100.18M
153.74%94.85M
155.51%89.84M
Lease liabilities
-23.35%24.36M
-23.21%24.26M
-21.69%28.32M
3.63%30.36M
-1.69%31.78M
-12.92%31.59M
188.09%36.16M
136.03%29.3M
244.47%32.32M
--36.27M
Total non current liabilities
-16.52%523.17M
-7.65%483.55M
-2.88%502.78M
28.07%649.41M
30.33%626.71M
-10.32%523.61M
19.37%517.71M
18.84%507.07M
-1.99%480.86M
22.33%583.85M
Total liabilities
-10.29%1.39B
-8.12%1.55B
-9.36%1.58B
-6.00%1.58B
-24.17%1.55B
-21.22%1.69B
5.22%1.74B
11.53%1.68B
11.16%2.04B
22.12%2.14B
Shareholders equity
Paid-in capital
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
0.00%791.93M
Capital reserve funds
-10.90%653.84M
-10.90%653.84M
-10.90%653.84M
-10.90%653.84M
0.25%733.84M
0.25%733.84M
-4.22%733.84M
-4.22%733.84M
-4.41%731.99M
-4.74%731.99M
Surplus reserve funds
5.54%314.57M
5.54%314.57M
5.54%314.57M
6.26%314.57M
0.00%298.07M
0.00%298.07M
0.00%298.07M
0.00%296.03M
0.91%298.07M
0.91%298.07M
Retained profit
-35.09%902.05M
-28.42%964.7M
-16.52%1.06B
8.17%1.12B
-24.55%1.39B
-23.97%1.35B
-25.50%1.26B
-29.66%1.04B
8.22%1.84B
12.49%1.77B
Less:Treasury stock
--15M
----
----
----
----
----
----
----
----
----
Other composite income
4.19%672.26K
-30.75%684.79K
-30.75%684.79K
-34.75%645.25K
-43.12%645.25K
-19.15%988.87K
-19.74%988.87K
-16.71%988.87K
-43.98%1.13M
-41.87%1.22M
Shareholders equity without minority interests
-17.61%2.65B
-14.08%2.73B
-8.83%2.82B
0.81%2.88B
-12.30%3.21B
-11.77%3.17B
-13.09%3.09B
-14.12%2.86B
3.04%3.66B
4.73%3.6B
Minority interests
-6.27%128.72M
-7.31%129.33M
-8.63%130.85M
-8.26%133.81M
-12.89%137.33M
78.08%139.52M
147.88%143.21M
145.49%145.85M
368.44%157.66M
17.25%78.35M
Total shareholder equity
-17.15%2.78B
-13.80%2.86B
-8.82%2.95B
0.37%3.02B
-12.33%3.35B
-9.86%3.31B
-10.51%3.23B
-11.32%3.01B
6.46%3.82B
4.96%3.67B
Total liabilityies and equity
-14.98%4.17B
-11.88%4.41B
-9.01%4.52B
-1.92%4.6B
-16.45%4.9B
-14.04%5B
-5.57%4.97B
-4.29%4.69B
8.05%5.87B
10.69%5.82B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion with explanatory notes
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
China Securities Tiantong Certified Public Accountants (Special General Partnership)
--
--
--
China Securities Tiantong Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -9.57%619.88M12.86%760.22M12.99%770.6M18.08%699.47M-24.33%685.49M-16.72%673.61M48.05%682.01M56.04%592.36M26.11%905.91M8.42%808.89M
Notes receivable and accounts receivable -29.41%492.61M-22.17%460.1M-9.30%536.77M22.29%692.32M14.63%697.86M-32.52%591.16M-22.41%591.82M-18.97%566.13M-23.01%608.81M4.08%876.11M
-Notes receivable -55.63%252.85M-28.62%239.51M-0.73%322.4M71.30%465.26M99.95%569.86M-35.15%335.54M-28.77%324.79M-24.09%271.61M-39.15%285M-9.40%517.39M
-Accounts receivable 87.31%239.75M-13.70%220.59M-19.72%214.37M-22.91%227.06M-60.47%128M-28.74%255.62M-12.96%267.03M-13.60%294.53M0.46%323.81M32.51%358.72M
Other receivables (including interest and dividends) -55.00%26.76M-43.72%35.75M-39.57%38.82M-40.66%33.26M-13.83%59.47M55.16%63.52M24.98%64.24M45.90%56.05M2.19%69.02M-28.49%40.94M
-Other receivable -----43.72%35.75M------------55.16%63.52M-------------28.49%40.94M
Advance payment -11.66%16.38M63.85%27.72M232.11%55.28M153.57%36.21M-53.99%18.54M-34.87%16.92M-61.42%16.65M4.49%14.28M36.06%40.3M83.31%25.98M
Inventories -15.52%552.83M-4.47%601.39M-1.48%614.26M-6.15%586.65M10.05%654.37M5.84%629.5M7.97%623.46M12.70%625.08M13.50%594.62M14.61%594.77M
Receivable financing -----79.49%30.78M--------------150.1M--148.69M--156.1M33.17%207.12M----
Other current assets 12.37%24.16M-65.52%27.53M-32.13%20M-30.66%21.23M-14.43%21.5M296.36%79.83M-14.11%29.46M-12.46%30.63M-46.48%25.12M-48.66%20.14M
Total current assets -18.93%1.73B-11.84%1.94B-5.59%2.04B1.40%2.07B-12.80%2.14B-6.85%2.2B11.74%2.16B18.64%2.04B5.07%2.45B6.74%2.37B
Non Current assets
Other equity investment 2.50%1.63M-20.42%1.63M-20.42%1.63M-22.36%1.59M-29.08%1.59M-13.23%2.05M-13.66%2.05M-21.56%2.05M-39.85%2.24M-46.47%2.36M
Long-term equity investment 0.18%35.22M0.04%35.22M-0.45%35.13M-0.97%35.07M-0.79%35.16M-0.74%35.21M-0.94%35.29M-0.69%35.41M-0.91%35.43M-1.75%35.47M
Fixed assets -----5.28%1.64B------------48.61%1.73B-------------3.21%1.16B
Constru in process -----71.46%6.48M-------------96.28%22.72M------------93.83%610.86M
Productive biological assets 244.00%15.91M181.43%12.64M114.17%9.23M50.78%6.25M20.40%4.62M21.54%4.49M20.79%4.31M22.31%4.14M23.27%3.84M23.65%3.7M
Intangible assets -8.85%319.02M-8.76%322.97M-8.68%326.94M-8.60%330.89M-4.37%349.98M-4.21%353.99M-4.20%358.03M-4.36%362.03M2.32%365.98M9.97%369.55M
Goodwill 0.00%164.04M0.00%164.04M0.00%164.04M0.00%164.04M-78.91%164.04M-78.91%164.04M-78.91%164.04M-78.91%164.04M23.10%777.66M23.10%777.66M
Long deferred expense -15.93%106.95M-15.83%111.8M-15.91%116.87M-15.50%123.13M-18.07%127.21M-18.79%132.82M-14.67%138.99M-14.19%145.72M-4.32%155.26M-5.17%163.55M
Deferred tax assets -63.38%85.09M-70.21%68.71M-76.37%54.82M18.62%55.58M12.98%232.37M12.10%230.64M15.11%232.01M48.84%46.86M7.98%205.67M8.36%205.75M
Usufruct assets -21.99%31.84M-21.18%34.03M-20.64%36.22M3.21%38.46M2.68%40.82M5.10%43.17M222.10%45.64M148.19%37.27M205.80%39.76M2,076.10%41.08M
Other non current assets -8.80%67.37M-12.73%69.53M-0.17%67.39M-1.20%62.42M88.89%73.87M2.09%79.67M-8.39%67.5M-12.74%63.17M-68.63%39.11M-46.69%78.04M
Total non current assets -11.92%2.43B-11.91%2.46B-11.63%2.49B-4.47%2.53B-19.07%2.76B-18.97%2.8B-15.60%2.81B-16.71%2.65B10.30%3.42B13.58%3.45B
Total assets -14.98%4.17B-11.88%4.41B-9.01%4.52B-1.92%4.6B-16.45%4.9B-14.04%5B-5.57%4.97B-4.29%4.69B8.05%5.87B10.69%5.82B
Liabilities
Current liabilities
Short term loan -28.36%290.83M-25.94%426.67M-28.61%446.01M-16.95%446.05M-49.15%405.96M-29.09%576.09M10.46%624.72M18.19%537.11M10.87%798.28M44.16%812.4M
Notes payable and accounts payable -27.95%127.42M23.20%173.72M20.37%182.31M-9.62%135.06M17.95%176.85M-10.45%141.01M3.02%151.46M6.03%149.43M21.91%149.93M40.83%157.47M
-Accounts payable -27.95%127.42M23.20%173.72M20.37%182.31M-9.62%135.06M17.95%176.85M-10.45%141.01M3.02%151.46M6.03%149.43M21.91%149.93M40.83%157.47M
Contract liabilities -19.56%25.37M12.77%47.47M-8.10%28.89M-56.27%29.52M-11.23%31.54M60.15%42.1M-43.26%31.44M24.67%67.51M1.19%35.53M-45.44%26.29M
Salaries payable -17.42%40.55M-5.13%34.57M-5.49%34.83M-6.36%55.99M-11.11%49.11M-38.90%36.44M-22.69%36.85M10.91%59.79M-31.84%55.25M-3.35%59.65M
Taxs payable -3.06%37.13M-32.86%34.4M-54.58%24.92M-55.47%28.87M-40.80%38.3M-12.12%51.23M-28.19%54.86M-17.81%64.84M-3.58%64.69M28.79%58.3M
Other payable (including interest and dividends) -34.47%73.31M-42.59%77.45M-36.96%88.09M-5.94%103.8M-52.50%111.86M-56.88%134.92M-27.54%139.75M-32.03%110.35M0.68%235.5M51.14%312.9M
-Interest payable -68.09%171.2K-76.76%171.2K-80.24%171.2K-84.53%171.2K-61.56%536.53K-75.31%736.53K-72.15%866.53K-63.89%1.11M-43.11%1.4M10.91%2.98M
-Other payable -----42.41%77.28M-------------56.70%134.18M------------51.67%309.91M
Non current liabilities due within one year 169.08%268.67M56.17%266.92M53.36%261.35M-27.03%122.85M-52.90%99.85M42.43%170.92M42.01%170.42M40.12%168.36M180.35%211.97M-46.91%120M
Other current liabilities -59.44%3.94M-47.39%6.05M-41.74%6.64M-51.42%7.45M-18.28%9.71M0.42%11.5M-16.61%11.4M5.52%15.33M-3.66%11.89M-14.81%11.45M
Total current liabilities -6.06%867.22M-8.33%1.07B-12.11%1.07B-20.73%929.59M-40.94%923.18M-25.30%1.16B0.19%1.22B8.65%1.17B15.94%1.56B22.03%1.56B
Current liabilities
Long term loan -36.48%280.8M-29.68%238.52M-28.62%248.42M12.88%387.22M36.62%442.07M-20.70%339.19M7.67%348.04M8.58%343.04M-4.36%323.59M26.90%427.74M
Long term account payable ----759.85%85.99M--------------10M----------------
Estimate liabilities -58.29%271.29K-42.01%581.85K-30.94%448.51K-19.92%520.05K--650.42K--1M--649.44K--649.44K--------
Deferred tax liabilities 6.26%35.04M-6.04%33.34M-0.01%35.62M10.43%37.44M9.55%32.98M18.26%35.48M16.37%35.62M10.27%33.9M4.56%30.1M5.91%30M
Long term deferred income -11.27%97.99M-5.15%100.86M6.15%103.22M6.12%106.31M16.43%110.43M18.37%106.34M44.47%97.24M48.20%100.18M153.74%94.85M155.51%89.84M
Lease liabilities -23.35%24.36M-23.21%24.26M-21.69%28.32M3.63%30.36M-1.69%31.78M-12.92%31.59M188.09%36.16M136.03%29.3M244.47%32.32M--36.27M
Total non current liabilities -16.52%523.17M-7.65%483.55M-2.88%502.78M28.07%649.41M30.33%626.71M-10.32%523.61M19.37%517.71M18.84%507.07M-1.99%480.86M22.33%583.85M
Total liabilities -10.29%1.39B-8.12%1.55B-9.36%1.58B-6.00%1.58B-24.17%1.55B-21.22%1.69B5.22%1.74B11.53%1.68B11.16%2.04B22.12%2.14B
Shareholders equity
Paid-in capital 0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M0.00%791.93M
Capital reserve funds -10.90%653.84M-10.90%653.84M-10.90%653.84M-10.90%653.84M0.25%733.84M0.25%733.84M-4.22%733.84M-4.22%733.84M-4.41%731.99M-4.74%731.99M
Surplus reserve funds 5.54%314.57M5.54%314.57M5.54%314.57M6.26%314.57M0.00%298.07M0.00%298.07M0.00%298.07M0.00%296.03M0.91%298.07M0.91%298.07M
Retained profit -35.09%902.05M-28.42%964.7M-16.52%1.06B8.17%1.12B-24.55%1.39B-23.97%1.35B-25.50%1.26B-29.66%1.04B8.22%1.84B12.49%1.77B
Less:Treasury stock --15M------------------------------------
Other composite income 4.19%672.26K-30.75%684.79K-30.75%684.79K-34.75%645.25K-43.12%645.25K-19.15%988.87K-19.74%988.87K-16.71%988.87K-43.98%1.13M-41.87%1.22M
Shareholders equity without minority interests -17.61%2.65B-14.08%2.73B-8.83%2.82B0.81%2.88B-12.30%3.21B-11.77%3.17B-13.09%3.09B-14.12%2.86B3.04%3.66B4.73%3.6B
Minority interests -6.27%128.72M-7.31%129.33M-8.63%130.85M-8.26%133.81M-12.89%137.33M78.08%139.52M147.88%143.21M145.49%145.85M368.44%157.66M17.25%78.35M
Total shareholder equity -17.15%2.78B-13.80%2.86B-8.82%2.95B0.37%3.02B-12.33%3.35B-9.86%3.31B-10.51%3.23B-11.32%3.01B6.46%3.82B4.96%3.67B
Total liabilityies and equity -14.98%4.17B-11.88%4.41B-9.01%4.52B-1.92%4.6B-16.45%4.9B-14.04%5B-5.57%4.97B-4.29%4.69B8.05%5.87B10.69%5.82B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion with explanatory notes------Unqualified opinion----
Auditor ------China Securities Tiantong Certified Public Accountants (Special General Partnership)------China Securities Tiantong Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.